Skip to content
Catalyst

fucoxanthinFinding

Fucoxanthin activates SIRT1

raisesInsufficient evidenceFinding

01 · The sentence it was drawn from

“Through activating SIRT1, fucoxanthin inhibits forkhead box O (FoxO) transcriptional activity to reduce protein degradation, induces autophagy to enhance degraded protein clearance, promotes mitochondrial function and diminishes apoptosis.”
Quoted verbatim from Fucoxanthin rescues dexamethasone induced C2C12 myotubes atrophy.
This finding among the 3 findings on its endpoint

fucoxanthin

SIRT1

activates

Who
C2C12 myotubes with dexamethasone-induced atrophy
Dose studied
fucoxanthin 10 μM

Insufficient evidencePMID 33865017 · 2021

02 · The study

Study
in vitro · not in humans
Duration
not reported

Evidence, by strength

  • strong
  • moderate
  • limited
  • very limited
  • insufficientthis finding

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M3J8RQK5FKD1MEFCCNEMTSVG